Scientists at USC Dornsife and the USC Michelson Center for Convergent Bioscience are hoping to spark drug research across the university by hosting a series of workshops starting Friday.
The grand opening ceremonies celebrate the latest cutting-edge facilities at the center, which brings together researchers from the university’s engineering and medical schools and the USC Dornsife College of Letters, Arts and Sciences.
Peter Kuhn of the USC Michelson Center for Convergent Bioscience will serve as deputy director of a new virtual cancer center, funded by a grant from the Department of Defense.
Dedicated space for the Convergent Science Institute in Cancer initiative aims to get biologists, physicists and chemists collaborating on cutting-edge ideas that benefit patients.
A USC-led team has developed advanced imaging techniques that allow for a uniquely detailed glimpse inside the body’s insulin factories.
USC grads Kyle McClary and John Paul Francis are bringing imaging technology out of the lab and onto researchers’ laptops and cellphones.
The findings from USC researchers provide a clear path to uncovering new drugs to control addiction, pain and neurological disorders such as epilepsy and muscle spasticity.
The decorated USC professor received an award from the Society for Research on Biological Rhythms for decades of research into the mustard plant.
A clash between modern lifestyles and circadian rhythms can lead to the development of obesity and breast cancer, USC scientist says
Scientists at the USC Michelson Center for Convergent Bioscience and Stanford University take first step toward a safer drug for reducing postpartum bleeding.
After years with no therapies, patients with phenylketonuria, or PKU, now have an available drug and a second is awaiting approval. A USC alumnus and scientist helped make it happen.
The goal: a navigation tool for oncology teams to select the best treatment options for patients based on the genetic characteristics of their cancer and their own health profile.
Academic researchers, family members and industry join forces to fight serious diseases. It’s what can happen at a place like the USC Michelson Center for Convergent Bioscience.
Diabetes affects 400 million people around the world. Scientists hope that their models of the cells behind the disease can unlock better treatment.
New method exploits magnetic properties of parasite byproduct to detect all strains of the disease.
Scientists develop method to repair damaged structures deep inside the ear.
USC researchers issue a call to scientists to help them create the first comprehensive model of a cell that is central to diabetes, the pancreatic beta cell.
USC Michelson Center scientists use metal-tagged markers and a patient’s blood sample, aiming for precise treatments of cancerous cells that spread to other organs.
Trojans investigate mouse and human kidneys to hasten new remedies for renal disease.
USC Viterbi team takes a key step forward in cancer research.
USC Michelson Center scientists are part of an international team developing new alternatives to easing pain in the midst of a national crisis.
The USC Iovine and Young Academy is starting work on a new track for students to help patients participate in their own care.
John O’Brien worked for nearly a decade to plan the state-of-the-art facility, part of the USC Michelson Center for Convergent Bioscience.
USC Viterbi imaging expert may never see patients, but her work could help save their lives.